BAXTER INTERNATIONAL INC acquired Epic Therapeutics, Inc. for $59M, a transaction completed in November 2002, structured as Acquisition of a drug-delivery technology company.
Epic Therapeutics, Inc. operates in Medication Delivery, is based in United States. Baxter acquired Epic Therapeutics, a drug-delivery company specializing in the formulation of drugs for injection or inhalation, including controlled-release protein therapeutics using its proprietary PROMAXX microsphere technology. The acquisition strengthened Baxter's drug-delivery portfolio.
Added the PROMAXX microsphere drug-formulation technology for injectable and inhaled controlled-release therapeutics.
Advisory firms were not disclosed for this transaction.